跳至主要内容
临床试验/TCTR20230421003
TCTR20230421003已完成不适用

Prevalence of and Clinical Outcome of Off-label Gabapentin Prescription in Orofacial Pain

Faculty of Dentistry, Prince of Songkla University0 个研究点目标入组 87 人开始时间: 2023年4月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
87

研究概览

简要总结

Gabapentin was commonly prescribed in orofacial pain, as the first clinicians' drug choice, and as an interim drug to wait for gene screening results in TN. Most of them were prescribed for trigeminal neuralgia with suboptimal doses. However, gabapentin showed significant pain reduction in orofacial pain, unfortunately, few achieved pain-free periods. few dental charts are showing potential misuse of gabapentin which clinicians prescribed the drug without ICD-10 code and clinical records.

研究设计

研究类型
Observational

入排标准

年龄范围
N/A (No limit) 至 N/A (No limit)(—)
性别
All

入选标准

  • All patients who were prescribed with gabapentin at Dental clinics, Faculty of Dentistry, PSU.

排除标准

  • 未提供

研究者

发起方
Faculty of Dentistry, Prince of Songkla University

相似试验